Moreover, TRPA1 promotes the development of degenerative cartilage changes and joint pain in osteoarthritis, when the expression of a potential mediator, cyclooxygenase 2 (COX-2), gets inhibited [12]. Here, PTGS2 is linked to osteoarthritis.